These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 35678474)

  • 1. Ulcerative injection site reaction after third COVID-19 vaccine dose with mRNA-1273.
    Barei F; Marletta DA; Marti-Marti I; Maronese CA; Genovese G; Marzano AV
    Dermatol Ther; 2022 Aug; 35(8):e15631. PubMed ID: 35678474
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed localized hypersensitivity reactions to COVID-19 mRNA vaccines: a 6-month retrospective study.
    Papadimitriou I; Bakirtzi K; Sotiriou E; Vakirlis E; Hatzibougias D; Ioannides D
    Clin Exp Dermatol; 2022 Jan; 47(1):157-158. PubMed ID: 34288056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series.
    Johnston MS; Galan A; Watsky KL; Little AJ
    JAMA Dermatol; 2021 Jun; 157(6):716-720. PubMed ID: 33978670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Vaccine Reactions in Dermatology: "Filling" in the Gaps.
    Rice SM; Ferree SD; Kourosh AS
    Cutis; 2021 Jun; 107(6):288-290. PubMed ID: 34314309
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine (Moderna) in a Cohort of Hospital Employees.
    Jacobson MA; Zakaria A; Maung Z; Hart C; McCalmont TH; Fassett M; Amerson E
    Clin Infect Dis; 2022 Mar; 74(4):591-596. PubMed ID: 34086881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.
    Wang M; Wen W; Zhou M; Wang C; Feng ZH
    Am J Cardiol; 2022 Mar; 167():155-157. PubMed ID: 35063268
    [No Abstract]   [Full Text] [Related]  

  • 7. Reactogenicity among health care workers following a BNT162b2 or mRNA-1273 second dose after priming with a ChAdOx1 nCOV-19 vaccine.
    Baldolli A; Fournier A; Verdon R; Michon J
    Clin Microbiol Infect; 2022 Jun; 28(6):885.e1-885.e5. PubMed ID: 35182759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus Vaccination Adverse Reactions and the Role of the Dermatologist.
    Pulsipher KJ; Presley CL; Waller JD; Szeto MD; Laughter MR; Dellavalle RP
    J Drugs Dermatol; 2021 Mar; 20(3):351-352. PubMed ID: 33683080
    [No Abstract]   [Full Text] [Related]  

  • 9. Ischemic colitis after COVID-19 mRNA vaccine.
    Mönkemüller K; Abdullayeva E; Manovski K; Cacho-Díaz M
    Endoscopy; 2022 Dec; 54(12):E765-E766. PubMed ID: 35561992
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of myocarditis in a 60-year-old man 48 h after mRNA vaccination against SARS-CoV2.
    Habedank D; Lagast A; Novoa-Usme M; Atmowihardjo I
    Clin Res Cardiol; 2022 Feb; 111(2):230-232. PubMed ID: 34731321
    [No Abstract]   [Full Text] [Related]  

  • 11. Reactivation of a BCG Vaccination Scar Following the First Dose of the Moderna COVID-19 Vaccine.
    Tao J; Rosenfeld D; Hsu J; Bhatia A
    Cutis; 2022 Mar; 109(3):148-149. PubMed ID: 35659140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Young Male With Myocarditis Following mRNA-1273 Vaccination Against Coronavirus Disease-2019 (COVID-19).
    Kaneta K; Yokoi K; Jojima K; Kotooka N; Node K
    Circ J; 2022 Mar; 86(4):721. PubMed ID: 34744118
    [No Abstract]   [Full Text] [Related]  

  • 13. Guillain-Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report.
    Masuccio FG; Comi C; Solaro C
    Acta Neurol Belg; 2022 Oct; 122(5):1369-1371. PubMed ID: 34767184
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed.
    Zin Tun GS; Gleeson D; Al-Joudeh A; Dube A
    J Hepatol; 2022 Mar; 76(3):747-749. PubMed ID: 34619252
    [No Abstract]   [Full Text] [Related]  

  • 15. Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine : Secondary Analysis of a Randomized Trial.
    Kumar D; Ferreira VH; Hall VG; Hu Q; Samson R; Ku T; Ierullo M; Majchrzak-Kita B; Tomlinson G; Gingras AC; Humar A
    Ann Intern Med; 2022 Feb; 175(2):226-233. PubMed ID: 34807716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vogt-Koyanagi-Harada Disease following mRNA-1273 (Moderna) COVID-19 Vaccination.
    Joo CW; Kim YK; Park SP
    Ocul Immunol Inflamm; 2022 Jul; 30(5):1250-1254. PubMed ID: 35404752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of systemic vasculitis following mRNA COVID-19 vaccination: a pharmacovigilance study.
    Mettler C; Terrier B; Treluyer JM; Chouchana L
    Rheumatology (Oxford); 2022 Nov; 61(12):e363-e365. PubMed ID: 35640943
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents.
    Ali K; Berman G; Zhou H; Deng W; Faughnan V; Coronado-Voges M; Ding B; Dooley J; Girard B; Hillebrand W; Pajon R; Miller JM; Leav B; McPhee R
    N Engl J Med; 2021 Dec; 385(24):2241-2251. PubMed ID: 34379915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe injection site reaction ensuing the first dose of mRNA COVID-19 vaccine.
    Pierobon E; Sechi A; Germi L; Pezzolo E; Trevisan G; Feliciani C; Naldi L
    Ital J Dermatol Venerol; 2022 Jun; 157(3):281-282. PubMed ID: 35373779
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID Arm After Moderna Booster in Healthcare Worker: A Case Report.
    Saifuddin A; Koesnoe S; Kurniati N; Sirait S; Arisanty R; Yunihastuti E
    Acta Med Indones; 2021 Jul; 53(3):326-330. PubMed ID: 34611073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.